"[52578790BD2C]" . "2"^^ . "1210-7832" . "Modern surgical and biological therapy of breast cancer"@en . "Modern\u00ED chirurgick\u00E1 a biologick\u00E1 l\u00E9\u010Dba karcinomu prsu" . . "RIV/00216224:14110/12:00064027!RIV13-MSM-14110___" . "N" . . "Karcinom prsu je nej\u010Dast\u011Bj\u0161\u00EDm n\u00E1dorem \u017Een v \u010Cesk\u00E9 republice (\u010CR). Dle \u00FAdaj\u016F N\u00E1rodn\u00EDho onkologick\u00E9ho registru (NOR) z roku 2007 je incidence karcinomu prsu 122,7 p\u0159\u00EDpad\u016F na 100 tis. \u017Een/rok. \u010CR obsazuje v incidenci karcinomu prsu u \u017Een 26. m\u00EDsto ve sv\u011Bt\u011B a 17. m\u00EDsto v Evrop\u011B. Ro\u010Dn\u011B je v \u010CR u \u017Een diagnostikov\u00E1no 6 500 t\u011Bchto n\u00E1dor\u016F, 1 700 \u2013 1 900 \u017Een na n\u011Bj zem\u0159e (data z roku 2007). Incidence vykazuje dlouhodob\u011B rostouc\u00ED trend (n\u00E1r\u016Fst o 32 % v roce 2007 oproti roku 1995), naopak mortalita je dlouhodob\u011B stabilizovan\u00E1 [obr.\u010D.1]. Na tomto p\u0159\u00EDzniv\u00E9m v\u00FDsledku se pod\u00EDl\u00ED zaveden\u00ED systematick\u00E9ho mamografick\u00E9ho screeningu u \u017Een nad 45 let v\u011Bku, diagnostika \u010Dasn\u00FDch st\u00E1di\u00ED nemoci, \u00FA\u010Dinn\u011Bj\u0161\u00ED adjuvantn\u00ED terapie a l\u00E9\u010Dba metastatick\u00E9ho onemocn\u011Bn\u00ED [obr.\u010D.2]. V mezin\u00E1rodn\u00EDm srovn\u00E1n\u00ED mortality je \u010CR na 71. m\u00EDst\u011B ve sv\u011Bt\u011B a na 27. m\u00EDst\u011B v Evrop\u011B. Zhoubn\u00FD novotvar prsu \u010Dasto postihuje \u017Eeny v produktivn\u00EDm v\u011Bku, t\u00E9m\u011B\u0159 43 % pacientek je mlad\u0161\u00EDch ne\u017E 60 let."@cs . . . "Modern\u00ED chirurgick\u00E1 a biologick\u00E1 l\u00E9\u010Dba karcinomu prsu"@cs . "Modern\u00ED chirurgick\u00E1 a biologick\u00E1 l\u00E9\u010Dba karcinomu prsu"@cs . . "Karcinom prsu je nej\u010Dast\u011Bj\u0161\u00EDm n\u00E1dorem \u017Een v \u010Cesk\u00E9 republice (\u010CR). Dle \u00FAdaj\u016F N\u00E1rodn\u00EDho onkologick\u00E9ho registru (NOR) z roku 2007 je incidence karcinomu prsu 122,7 p\u0159\u00EDpad\u016F na 100 tis. \u017Een/rok. \u010CR obsazuje v incidenci karcinomu prsu u \u017Een 26. m\u00EDsto ve sv\u011Bt\u011B a 17. m\u00EDsto v Evrop\u011B. Ro\u010Dn\u011B je v \u010CR u \u017Een diagnostikov\u00E1no 6 500 t\u011Bchto n\u00E1dor\u016F, 1 700 \u2013 1 900 \u017Een na n\u011Bj zem\u0159e (data z roku 2007). Incidence vykazuje dlouhodob\u011B rostouc\u00ED trend (n\u00E1r\u016Fst o 32 % v roce 2007 oproti roku 1995), naopak mortalita je dlouhodob\u011B stabilizovan\u00E1 [obr.\u010D.1]. Na tomto p\u0159\u00EDzniv\u00E9m v\u00FDsledku se pod\u00EDl\u00ED zaveden\u00ED systematick\u00E9ho mamografick\u00E9ho screeningu u \u017Een nad 45 let v\u011Bku, diagnostika \u010Dasn\u00FDch st\u00E1di\u00ED nemoci, \u00FA\u010Dinn\u011Bj\u0161\u00ED adjuvantn\u00ED terapie a l\u00E9\u010Dba metastatick\u00E9ho onemocn\u011Bn\u00ED [obr.\u010D.2]. V mezin\u00E1rodn\u00EDm srovn\u00E1n\u00ED mortality je \u010CR na 71. m\u00EDst\u011B ve sv\u011Bt\u011B a na 27. m\u00EDst\u011B v Evrop\u011B. Zhoubn\u00FD novotvar prsu \u010Dasto postihuje \u017Eeny v produktivn\u00EDm v\u011Bku, t\u00E9m\u011B\u0159 43 % pacientek je mlad\u0161\u00EDch ne\u017E 60 let." . "Min\u00E1\u0159, Lubo\u0161" . "77" . . . . . . "\u010Cesk\u00E1 gynekologie" . "151310" . . "Modern\u00ED chirurgick\u00E1 a biologick\u00E1 l\u00E9\u010Dba karcinomu prsu" . "Modern surgical and biological therapy of breast cancer"@en . "breast cancer; surgery; chemoterapy; biological therapy"@en . "8"^^ . . "CZ - \u010Cesk\u00E1 republika" . "RIV/00216224:14110/12:00064027" . "Breast cancer is the most common cancer of women in the Czech Republic. According to data from the National Cancer Registry (NOR) in 2007, the incidence is 122,7 cases of breast cancer in 100 000 women per year. Czech Republic occupies in the incidence of women brest cancer 26th place in the world and 17th place in Europe. Annualy it haa benn diagnosed 6500 these tumors, 1700 \u2013 1900 women die for him in the Czech Republic (data from 2007). The incidence show long-term upward trend (an increase of 32% in 2007 compared to 1995), while mortality has long been stabilized [Figure 1]. In this favorable outcome ivolved the introduction of systematic screeningu mammography in women over 45 years of age, diagnosis of early stages of disease, effective adjutant therapy and treatment of metastatic disease [Figure 2]. In an international comparison of mortality, the Czech Republic belongs to 71th place in the world and the 27th place in Europe."@en . . . . . . "14110" . "2"^^ . "Weinberger, V\u00EDt" . "6" .